Clinical Trials Browser

Has results × Leukemia, Erythroblastic, Acute × Alemtuzumab × Clear all

NCT02497404 2021-09-22

Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

Phase 2 Completed

40 enrolled 21 charts

MyeloidOther hematologic neoplasm

Leukemia, Erythroblastic, Acute, Myelodysplastic Syndromes